Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 status

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

(2012) Hiroaki Nitta et al.   Diagnostic Pathology

Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer

(2012) Xiaopeng Cai et al.   Diagnostic Pathology

A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas

(2012) Asli Cakir et al.   Diagnostic Pathology

Apoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer

(2012) Yaxiong Guo et al.   Diagnostic Pathology

Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis

(2012) Xue Qin et al.   Diagnostic Pathology

Doxorubicin Influences the Expression of Glucosylceramide Synthase in Invasive Ductal Breast Cancer

(2012) Xiaofang Zhang et al.   PLoS One

Co-suppression of MDR1 (multidrug resistance 1) and GCS（glucosylceramide synthase）restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi)

(2010) Xiaofang Zhang et al.   CANCER BIOLOGY & THERAPY

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

(2009) Yanlin Sun et al.   BREAST CANCER RESEARCH AND TREATMENT

An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment

(2008) Corine Ekhart et al.   CANCER TREATMENT REVIEWS

Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer

(2008) Eugen Ruckhäberle et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY